[Pfizer's answer to Bengt Jarhult: joint challenge to develop methods for discovery of low-frequency adverse effects].
Dahl
Eva
E
eva.dahl@pfizer.com
Lindstrand
Gisela
G
D004345:Drug Industry; D004346:Drug Information Services; D004335:Drug and Narcotic Control; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans